Literature DB >> 20846630

Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype.

Owen J T McCarty1, Robert B Conley, Weihui Shentu, Garth W Tormoen, Daogang Zha, Aris Xie, Yue Qi, Yan Zhao, Chad Carr, Todd Belcik, Douglas R Keene, Philip G de Groot, Jonathan R Lindner.   

Abstract

OBJECTIVES: We hypothesized that noninvasive molecular imaging of activated von Willebrand factor (vWF) on the vascular endothelium could be used to detect a high-risk atherosclerotic phenotype.
BACKGROUND: Platelet-endothelial interactions have been linked to increased inflammatory activation and prothrombotic state in atherosclerosis. These interactions are mediated, in part, by platelet glycoprotein (GP) Ibα, suggesting that dysregulated endothelial vWF is a marker for high-risk atherosclerotic disease.
METHODS: Microbubbles targeted to activated vWF were prepared by surface conjugation of recombinant GPIbα. Flow-chamber studies were used to evaluate attachment of targeted microbubbles to immobile platelet aggregates bearing activated vWF. Contrast-enhanced ultrasound (CEU) molecular imaging of the aorta from mice was performed: 1) ex vivo after focal crush injury and blood perfusion; and 2) in vivo in mice with advanced atherosclerosis produced by deletion of the low-density lipoprotein receptor and ApoBec-1 editing peptide (LDLR(-/-)/ApoBec-1(-/-)).
RESULTS: In flow-chamber studies, tracer attachment to vWF was >10-fold greater for microbubbles bearing GPIbα compared with control microbubbles (p < 0.01). In the ex vivo aortic injury model, CEU signal enhancement for vWF-targeted microbubbles occurred primarily at the injury site and was 4-fold greater than at noninjured sites (p < 0.05). In LDLR(-/-)/ApoBec-1(-/-) mice, inflammatory cell infiltrates and dense vWF expression on the intact endothelium were seen in regions of severe plaque formation. Scanning electron microscopy demonstrated widespread platelet-endothelial interaction and only few sites of endothelial erosion. On CEU, signal enhancement for vWF-targeted microbubbles was approximately 4-fold greater (p < 0.05) in LDLR(-/-)/ApoBec-1(-/-) compared with wild-type mice. En face aortic microscopy demonstrated regions where platelet adhesion and microbubble attachment colocalized.
CONCLUSIONS: Molecular imaging using GPIbα as a targeting moiety can detect the presence of activated vWF on the vascular endothelium. This strategy may provide a means to noninvasively detect an advanced prothrombotic and inflammatory phenotype in atherosclerotic disease.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846630      PMCID: PMC3204804          DOI: 10.1016/j.jcmg.2010.06.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  18 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

Authors:  K Kaikita; K Soejima; M Matsukawa; T Nakagaki; H Ogawa
Journal:  J Thromb Haemost       Date:  2006-08-08       Impact factor: 5.824

4.  Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia.

Authors:  Gregor Theilmeier; Carine Michiels; Erik Spaepen; Ingrid Vreys; Désiré Collen; Jos Vermylen; Marc F Hoylaerts
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

5.  Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes.

Authors:  J R Lindner; M P Coggins; S Kaul; A L Klibanov; G H Brandenburger; K Ley
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

6.  Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin.

Authors:  J R Lindner; J Song; J Christiansen; A L Klibanov; F Xu; K Ley
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

7.  Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.

Authors:  Michelle A Berny; Tara C White; Erik I Tucker; Leslie A Bush-Pelc; Enrico Di Cera; András Gruber; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-25       Impact factor: 8.311

Review 8.  The molecular mechanisms of the thrombotic complications of atherosclerosis.

Authors:  P Libby
Journal:  J Intern Med       Date:  2008-05       Impact factor: 8.989

9.  Intravascular ultrasound molecular imaging of atheroma components in vivo.

Authors:  Andrew J Hamilton; Shao-Ling Huang; Drew Warnick; Mark Rabbat; Bonnie Kane; Ashwin Nagaraj; Melvin Klegerman; David D McPherson
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

10.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  26 in total

1.  In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.

Authors:  Andrei Maiseyeu; Marcus A Badgeley; Thomas Kampfrath; Georgeta Mihai; Jeffrey A Deiuliis; Cuiqing Liu; Qinghua Sun; Sampath Parthasarathy; Daniel I Simon; Kevin Croce; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

2.  Molecular imaging of thrombus: technology in evolution.

Authors:  Jonathan R Lindner
Journal:  Circulation       Date:  2012-05-30       Impact factor: 29.690

3.  Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.

Authors:  Koya Ozawa; William Packwood; Oleg Varlamov; Yue Qi; Aris Xie; Melinda D Wu; Zaverio Ruggeri; Jose A López; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

4.  Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.

Authors:  Chi Young Shim; Ya Ni Liu; Tamara Atkinson; Aris Xie; Ted Foster; Brian P Davidson; Mackenzie Treible; Yue Qi; José A López; Adam Munday; Zaverio Ruggeri; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

Review 5.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

6.  Measurement science in the circulatory system.

Authors:  Casey M Jones; Sandra M Baker-Groberg; Flor A Cianchetti; Jeremy J Glynn; Laura D Healy; Wai Yan Lam; Jonathan W Nelson; Diana C Parrish; Kevin G Phillips; Devon E Scott-Drechsel; Ian J Tagge; Jaime E Zelaya; Monica T Hinds; Owen J T McCarty
Journal:  Cell Mol Bioeng       Date:  2014-03       Impact factor: 2.321

7.  Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies.

Authors:  Fei Yan; Xiang Li; Qiaofeng Jin; Juanjuan Chen; Robin Shandas; Junru Wu; Lu Li; Tao Ling; Wei Yang; Yun Chen; Xin Liu; Hairong Zheng
Journal:  Ultrasound Med Biol       Date:  2012-02-16       Impact factor: 2.998

Review 8.  Molecular imaging of disease with targeted contrast ultrasound imaging.

Authors:  Yoichi Inaba; Jonathan R Lindner
Journal:  Transl Res       Date:  2012-01-04       Impact factor: 7.012

9.  Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition.

Authors:  Yani Liu; Brian P Davidson; Qi Yue; Todd Belcik; Aris Xie; Yoichi Inaba; Owen J T McCarty; Garth W Tormoen; Yan Zhao; Zaverio M Ruggeri; Beat A Kaufmann; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2012-12-13       Impact factor: 7.792

Review 10.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.